- Home
- NVGS vs GPCR Comparison
NVGS vs GPCR Comparison
Compare NVGS & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- GPCR
- Stock Information
- Founded
- NVGS 1997
- GPCR 2016
- Country
- NVGS United Kingdom
- GPCR United States
- Employees
- NVGS N/A
- GPCR N/A
- Industry
- NVGS Marine Transportation
- GPCR
- Sector
- NVGS Consumer Discretionary
- GPCR
- Exchange
- NVGS Nasdaq
- GPCR Nasdaq
- Market Cap
- NVGS 994.3M
- GPCR 1.1B
- IPO Year
- NVGS N/A
- GPCR 2023
- Fundamental
- Price
- NVGS $16.63
- GPCR $22.08
- Analyst Decision
- NVGS Strong Buy
- GPCR Strong Buy
- Analyst Count
- NVGS 2
- GPCR 9
- Target Price
- NVGS $21.50
- GPCR $75.63
- AVG Volume (30 Days)
- NVGS 304.9K
- GPCR 1.1M
- Earning Date
- NVGS 11-05-2025
- GPCR 08-06-2025
- Dividend Yield
- NVGS 1.23%
- GPCR N/A
- EPS Growth
- NVGS 12.51
- GPCR N/A
- EPS
- NVGS 1.26
- GPCR N/A
- Revenue
- NVGS $566,889,000.00
- GPCR N/A
- Revenue This Year
- NVGS $2.20
- GPCR N/A
- Revenue Next Year
- NVGS N/A
- GPCR N/A
- P/E Ratio
- NVGS $12.94
- GPCR N/A
- Revenue Growth
- NVGS 1.19
- GPCR N/A
- 52 Week Low
- NVGS $10.55
- GPCR $13.22
- 52 Week High
- NVGS $17.53
- GPCR $45.37
- Technical
- Relative Strength Index (RSI)
- NVGS 62.56
- GPCR 68.89
- Support Level
- NVGS $15.88
- GPCR $18.49
- Resistance Level
- NVGS $16.27
- GPCR $21.23
- Average True Range (ATR)
- NVGS 0.33
- GPCR 1.25
- MACD
- NVGS 0.02
- GPCR 0.28
- Stochastic Oscillator
- NVGS 99.61
- GPCR 95.74
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.